One of the key players in mediating pro-inflammatory signaling is the Janus Kinase (JAK) 1/2. Signaling via JAK1/2 and signal transducer and activator of transcription (STAT) pathways are crucial for ...

The cannabidiol (CBD) world can feel huge and complicated, but products like CBD gummies make it more approachable for some folks. CBD gummies are easy to dose, portable, and discreet. They also ...

Phil will then provide a financial overview and review our 2025 guidance, and then we'll open the call for Q&A. Renée? Thanks, Bruce. Before I cover individual commercial products, I'd like to ...

The Adani group is planning to invest Rs 30,000 crore in Kerala over next five years, a top official of the company said here Friday. The investments include Rs 5,500 crore on expanding the ...

Rebel Foods, the operator behind brands like Faasos, Oven Story, Behrouz Biryani, Wendy’s, and Smoor, has leveraged its cloud kitchen network to enter the quick commerce space in Mumbai—at a ...

Stepan Company (NYSE:SCL) Q4 2024 Earnings Call Transcript February 19, 2025 Stepan Company misses on earnings expectations. Reported EPS is $0.1462 EPS, expectations were $0.45. Operator ...

Good morning, and welcome to the Stepan Company Fourth Quarter 2024 Earnings Conference Call. During the presentation all participants will be in a listen-only mode. Afterward, we will conduct a ...

Icon PLC (ICLR) came out with quarterly earnings of $3.43 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.46 per share a year ago. These figures are ...

Stepan Company (NYSE:SCL), a dividend aristocrat that has raised its dividend for 54 consecutive years, reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of $0.12, ...

Stepan Co. (SCL) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.33 per share a year ago. These ...

Stepan Co (NYSE:SCL) is set to release its Q4 2024 earnings on Feb 19, 2025. The consensus estimate for Q4 2024 revenue is $0.52 billion, and the earnings are expected to come in at $0.31 per share.